Clinical trial Recruiting at 1 site Interventional Ages 40 and up

Home-based screening for undiagnosed heart failure

Official title: Uppsala Self-SCREENing of Heart Failure Study

Run by Uppsala University · NCT06940544 · Data updated 2026-11-12

This study tests a new home screening method to see if it can help find undiagnosed heart failure in high-risk patients better than regular care.

Quick facts

Study typeInterventional
Ages40 Years and up
SexAll
Enrollment500 (estimated)
SponsorUppsala University
Academic / other
Locations1 site (Uppsala)
StatusRecruiting
StartedFebruary 1, 2023
Main results expectedAugust 1, 2026
Study endsAugust 1, 2026
Registry record updatedApril 23, 2025
Trial IDNCT06940544 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 40 and older with symptoms of heart failure and at least two risk factors for the condition.

Probably not a fit

Patients who have previously been diagnosed with heart failure or have undergone renal replacement therapy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates a stepwise multimodal home-based screening strategy using rapid point-of-care testing to detect undiagnosed heart failure in high-risk patients. It compares this approach to usual care to determine if it increases the diagnosis of heart failure within six months and leads to more patients receiving guideline-directed medical therapy. The study also evaluates the long-term impact of earlier diagnosis on hospitalizations, mortality, functional capacity, quality of life, and healthcare costs over one, two, and five years.

Why it matters

Potential benefit: If successful, this approach could lead to earlier diagnosis and treatment of heart failure, improving patient outcomes and quality of life.

How similar studies have gone: Other studies have shown promise in home-based screening approaches for heart failure, suggesting potential for success in this novel application.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Age ≥40 years, and at least one of the following symptoms of HF, and at least two risk factors for HF:

Symptoms

* Dyspnoea on exertion
* Dyspnoea at rest
* Orthopnoea
* Paroxysmal nocturnal dyspnoea
* Reduced exercise tolerance, increased time to recover after exercise
* Fatigue, tiredness
* Ankle swelling

Risk factors

* Diabetes (type 1 or type 2)
* Coronary artery disease (myocardial infarction or coronary artery bypass grafting or percutaneous coronary intervention)
* Persistent or permanent atrial fibrillation (not paroxysmal atrial fibrillation)
* Previous ischemic or embolic stroke
* Peripheral arterial disease (previous surgical or percutaneous revascularisation)
* Chronic kidney disease
* Regular loop diuretic use (any dose at any dosing interval) for \>30 days
* COPD (diagnosis by respiratory physician, radiological emphysema or treatment with advocated COPD therapy)

Exclusion Criteria:

* Previous diagnosis of HF
* Previous renal replacement therapy
* Inability to comply with study procedures or provide informed consent

Where it's running

  • Uppsala Akademiska Hospital
    Uppsala, Sweden
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.